BTG Plc (BTG) - Product Pipeline Analysis, 2015 Update

Transcription

1 Publication Date: June 2015 Page 1

2 Table of Contents Table of Contents... 2 List of Tables... 3 List of Figures... 5 BTG Plc Company Snapshot... 6 BTG Plc Company Overview... 6 Key Information... 7 BTG Plc Pipeline Products and Clinical Trials Overview... 8 BTG Plc Pipeline Analysis Overview Business Description Key Facts BTG Plc - Major Products and Services BTG Plc Pipeline Products by Development Stage BTG Plc Clinical Trials by Trial Status BTG Plc Pipeline Products Overview CellBead - Neuro CellBead - Neuro Product Overview DC Bead DC Bead Product Overview DC Bead Clinical Trial DC Bead M DC Bead M1 Product Overview EKOS EkoSonic SV System - Neuro Vasculature EKOS EkoSonic SV System - Neuro Vasculature Product Overview RePneu Lung Volume Reduction Coil RePneu Lung Volume Reduction Coil Product Overview RePneu Lung Volume Reduction Coil Clinical Trial TheraSphere - HCC TheraSphere - HCC Product Overview TheraSphere - HCC Clinical Trial TheraSphere - mcrc TheraSphere - mcrc Product Overview TheraSphere - mcrc Clinical Trial Varithena - Aesthetic Leg Veins Varithena - Aesthetic Leg Veins Product Overview BTG Plc - Key Competitors BTG Plc - Key Employees BTG Plc - Key Employee Biographies BTG Plc - Locations And Subsidiaries Head Office Other Locations & Subsidiaries Recent Developments Appendix Methodology About GlobalData Disclaimer Page 2

3 List of Tables BTG Plc, Key Facts... 7 BTG Plc Pipeline Products and Clinical Trials Overview... 8 BTG Plc Pipeline Products by Equipment Type... 8 BTG Plc Pipeline Products by Indication... 9 BTG Plc Clinical Trials by Trial Status... 9 BTG Plc, Key Facts BTG Plc, Major Products and Services BTG Plc Number of Pipeline Products by Development Stage BTG Plc Pipeline Products Summary by Development Stage BTG Plc Clinical Trials by Trial Status BTG Plc Clinical Trials Summary CellBead - Neuro - Product Status CellBead - Neuro - Product Description DC Bead - Product Status DC Bead - Product Description DC Bead - Post-marketing Surveillance of DC Bead in Patients with Hepatocellular Carcinoma DC Bead M1 - Product Status DC Bead M1 - Product Description EKOS EkoSonic SV System - Neuro Vasculature - Product Status EKOS EkoSonic SV System - Neuro Vasculature - Product Description RePneu Lung Volume Reduction Coil - Product Status RePneu Lung Volume Reduction Coil - Product Description RePneu Lung Volume Reduction Coil - Crossover From IDE Trial CLN0009, Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study, IDE G RePneu Lung Volume Reduction Coil - Evaluation of the PneumRx, Inc. Lung Volume Reduction Coil for the Treatment of Emphysema in Alpha-1 Antitrypsin Deficient Patients RePneu Lung Volume Reduction Coil - Identifying Responders and Exploring Mechanisms of Action of the Endobronchial Coil Treatment for Emphysema RePneu Lung Volume Reduction Coil - Lung Volume Reduction Coil Treatment in Patients with Emphysema (RENEW) Study RePneu Lung Volume Reduction Coil - Post Market Observational, Prospective, Multi-center Registry Using the PneumRx, Inc. Lung Volume Reduction Coil (LVRC) System RePneu Lung Volume Reduction Coil - The Safety and Feasibility of Re-treating Patients with Severe Emphysema with the RePneu LVRC System: A Pilot Study TheraSphere - HCC - Product Status TheraSphere - HCC - Product Description TheraSphere - HCC - A Humanitarian Device Exemption Compassionate Use Protocol of Therasphere for Treatment of Unresectable Metastatic Cancer to the Liver TheraSphere - HCC - A Humanitarian Device Exemption Treatment Protocol of Therasphere for the Treatment of Unresectable Hepatocellular Carcinoma TheraSphere - HCC - A Humanitarian Device Exemption Treatment Protocol of TheraSphere for Treatment of Unresectable Hepatocellular Carcinoma TheraSphere - HCC - A Humanitarian Device Exemption Use Protocol of TheraSphere for Treatment of Unresectable Hepatocellular Carcinoma Page 3

4 TheraSphere - HCC - A Humanitarian Device Exemption Use Protocol of TheraSphere for Treatment of Unresectable Hepatocellular Carcinoma TheraSphere - HCC - A Phase II Clinical Trial Evaluating Overall Survival with Therasphere In Conjunction with 2nd-Line FOLFOX In Patients with Gemcitabine-Refractory Pancreatic Carcinoma with Liver Metastases TheraSphere - HCC - A Phase III Clinical Trial of Intra-arterial TheraSphere in the Treatment of Patients with Unresectable Hepatocellular Carcinoma (HCC) TheraSphere - HCC - A Prospective Investigation of Definitive Targeted Therapy for Solid Malignancies with Oligometastases TheraSphere - HCC - A Prospective Randomized Clinical Trial on 90Yttrium Trans-arterial Radio-Embolization (TheraSphere) Versus Standard of Care (Sorafenib) for the Treatment of Advanced Hepatocellular Carcinoma (HCC) with Portal Vein Thrombosis (PVT) TheraSphere - HCC - Phase II Study of Intrahepatic Arterial Injection of 90-Y Glass Microspheres as First-line Treatment for Cholangiocarcinoma TheraSphere - HCC - Protocol for Use of Therasphere for Treatment of Unresectable Hepatocellular Carcinoma TheraSphere - HCC - TheraSphere Yttrium-90 Glass: Humanitarian Device Exemption Use Protocol for TheraSphere for Treatment of Unresectable Hepatocellular Carcinoma TheraSphere - mcrc - Product Status TheraSphere - mcrc - Product Description TheraSphere - mcrc - A Phase III Clinical Trial Evaluating Therasphere in Patients with Metastatic Colorectal Carcinoma of the Liver Who Have Failed First Line Chemotherapy TheraSphere - mcrc - An Open-label, Multicenter, Phase II Trial, to Evaluate the Efficacy of Intra-hepatic Administration of Yttrium 90-labelled Microspheres (Therasphere, Nordion) in Association with Intravenous Chemotherapy with Gemcitabine and Cisplatin for the Treatment of Intra-hepatic Cholangiocarcinoma, First Line Varithena - Aesthetic Leg Veins - Product Status Varithena - Aesthetic Leg Veins - Product Description BTG Plc, Key Employees BTG Plc, Key Employee Biographies BTG Plc, Subsidiaries Page 4

5 List of Figures BTG Plc Pipeline Products by Equipment Type... 9 BTG Plc Pipeline Products by Development Stage BTG Plc Clinical Trials by Trial Status Page 5

6 BTG Plc Company Snapshot BTG Plc Company Overview BTG plc (BTG) is an international healthcare company that develops manufactures and sells innovative products in specialized areas of medicine. The company undertakes the development of specialty pharmaceutical products including antidotes for the treatment of snake envenomation and toxicity related with medicines used for heart conditions and cancerinterventional vascular products for treating patients with severe blood clots and varicose veins in the great saphenous vein system of the legand interventional oncology products for treating patients with liver tumors. The company develops its own products and acquires or in-licenses them from others. The company markets its products either directly or through distribution agreements. The company operates along with its subsidiaries in the US, the UK, Guernsey, Australia and Germany. BTG is headquartered in London, the UK. Page 6

7 Key Information BTG Plc, Key Facts Web Address Turnover (in USD Million) Industry Telephone Ticker Symbol No. of Employees Fiscal Year End Fax Price As of Jun, 2015 Page 7

8 BTG Plc Pipeline Products and Clinical Trials Overview BTG Plc Pipeline Products and Clinical Trials Overview Type No of Products BTG Plc Pipeline Products by Equipment Type Category No of Products No of Clinical Trials Page 8

9 BTG Plc Pipeline Products by Equipment Type Source: Primary and Secondary Research, GlobalData BTG Plc Pipeline Products by Indication Indication No of Products BTG Plc Clinical Trials by Trial Status Trial Status No of Clinical Trials Page 9

10 BTG Plc Pipeline Analysis Overview Business Description Key Facts BTG Plc, Key Facts Corporate Address Telephone Fax URL Industry Locations Ticker Symbol, Exchange No. of Employees Fiscal Year End Revenue (in USD Million) Revenue (in GBP Million) Page 10

11 BTG Plc - Major Products and Services BTG Plc, Major Products and Services Products: Page 11

12 BTG Plc Pipeline Products by Development Stage BTG Plc Pipeline Products by Development Stage Source: Primary and Secondary Research, GlobalData BTG Plc Number of Pipeline Products by Development Stage Developmental Stage No of Products Page 12

13 BTG Plc Pipeline Products Summary by Development Stage Product Name Developmental Stage Equipment Type Territory Page 13

14 BTG Plc Clinical Trials by Trial Status BTG Plc Clinical Trials by Trial Status Source: Primary and Secondary Research, GlobalData BTG Plc Clinical Trials by Trial Status Trial Status No of Clinical Trials Page 14

15 BTG Plc Clinical Trials Summary Product Name Clinical Trial Title Clinical Trial Status Actual/Estim ated Start Date Actual/Estim ated End Date Page 15

16 BTG Plc Pipeline Products Overview CellBead - Neuro CellBead - Neuro Product Overview CellBead - Neuro - Product Status CellBead - Neuro - Product Description Page 16

17 DC Bead DC Bead Product Overview DC Bead - Product Status DC Bead - Product Description Page 17

18 DC Bead Clinical Trial DC Bead - Post-marketing Surveillance of DC Bead in Patients with Hepatocellular Carcinoma Trial Name: Page 18

19 DC Bead M1 DC Bead M1 Product Overview DC Bead M1 - Product Status DC Bead M1 - Product Description Page 19

20 BTG Plc - Key Competitors Page 33

21 BTG Plc - Key Employees BTG Plc, Key Employees Name Job Title Board Level Since Age Page 34

22 BTG Plc - Key Employee Biographies BTG Plc, Key Employee Biographies Page 35

23 BTG Plc - Locations And Subsidiaries Head Office Other Locations & Subsidiaries BTG Plc, Subsidiaries Page 36

24 Recent Developments Page 37

25 Appendix The data and analysis within this report is driven by GlobalData. GlobalData gives you key information to drive sales, investment and deal making activity in your business. Our coverage includes 200,000 + reports on 185,000+ companies (including 150,000+ private) across 200+ countries and 29 industries. The key industries include Alternative Energy, Oil & Gas, Clean Technology, Technology and Telecommunication, Pharmaceutical and Healthcare, Power, Financial Services, Chemical and Metal & Mining. Methodology GlobalData company reports are based on a core set of research techniques which ensure the best possible level of quality and accuracy of data. The key sources used include: Company Websites Company Annual Reports SEC Filings Press Releases Proprietary Databases Notes Financial information for the company is taken from the most recently published annual reports or SEC filings The financial and operational data reported for the company is as per the industry defined standards Currencies are converted at current rates, with average annual rates taken for historic conversions Only Ongoing clinical trials are covered in the report specific to the pipeline products In the 'Major Products and Services section, complete list of products are not provided 'Recent Developments' section has news posted in the last three months About GlobalData GlobalData is one of the world s leading providers of company operational data and strategic analysis, providing detailed information on tens of thousands of companies globally. Our highly qualified team of Analysts, Researchers, and Solution Consultants use proprietary data sources and various tools and techniques to gather, analyze and represent the latest and the most reliable information essential for businesses to sustain a competitive edge. Data is continuously updated and revised by large teams of research experts, so that it always reflects the latest events and information. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research material for this series and its other reports. GlobalData offers comprehensive geographic coverage across world s most important sectors, focusing particularly on energy and healthcare. Disclaimer All Rights Reserved No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior permission of the publisher, GlobalData Page 38